Biochem-01-Molec_Cell_Lab Flashcards
Chromatin structure
Beads on a string: DNA loops twice around nucleosome (positively-charged histone octamer)
Histones and Nucleosomes
- Positively-charged: Rich with lysine and arginine
- Nucleosome: Two each of H2A, H2B, H3, H4
- H1 ties nucleosome beads together; it’s not part of nucleosome core; it helps keep the DNA around the bead
Heterochromatin
Highly condensed, transcriptionally inactive, sterically inaccessible
Euchromatin
Less condensed, transcriptionally active, sterically accessible
DNA methylation
- Cytosine and adenine are methylated after DNA replication; it allows mismatch repair enzymes to distinguish between old and new strants
- Methylating a DNA sequence also silences it
Histone methylation
- Inactivates transcritpion of DNA
* {Methylation makes DNA Mute}
Histone acetylation
- Relaxes DNA coiling by reducing the positive charge of histones, allowing for transcription
- {Acetylation makes DNA Active}
Purines and their general structure
- Adenine and guanine {PURe As Gold}
* 2 rings
Amino acids necessary for purine synthesis
- Glycine
- Aspartate
- Glutamine
Pyrimidines and their general structure
- Cytosine, Thymine, Uracil {CUT the PY}
* 1 ring
Structural features of guanine
Guanine has a ketone and an amine
Structural features of thymine
- Thymine has a methyl and two ketones
* found only in DNA
Structural features of adenine
Adenine has an amine group
Structural features of cytosine
Cytosine has a ketone and an amine
Structural features of uracyl
- Deamination of cytosine makes uracyl; [it has two ketones]
* found only in RNA
Hydrogen bonding of bases
- G-C has 3 hydrogen bonds and is thus stronger
* A-T (or A-U) has 2 hydrogen bonds and is thus weaker
Nucleoside vs. Nucleotide
- Nucleoside: base bound to sugar
* Nucleotide: phosphorylated nucleoside
Bond that links nucleotides with other nucleotides
3’-5’ phosphodiester bond
Role and synthesis of PRPP (5-phosphoribosyl-1-pyrophosphate)
- It’s an activated pentose that participates in the synthesis and salvage of purines and pyrimidines
- formed from Ribose 5-P
De novo pyrimidine synthesis
• General: make temporary base (orotic acid) and then add sugar and phosphate (PRPP)
• Requires aspartate
1. Carbamoyl phosphate made from glutamine and CO2
2. Aspartate added to carbamoyl phosphate and after a few steps, ortic acid is made
3. Orotic acid is combined with PRPP to make UMP (Uridine 5’-monophosphate); it is phosphorylated to make UDP (or UTP)
4. CTP is made by aminating UTP; glutamine provides the amine
5. UDP is converted to dUDP by ribonucleotide reductase and then converted to dUMP
6. dUMP is converted to dTMP by thymidylate synthase; N5,N10-Methylene THF provides the methyl group
Role of folate in pyrimidine synthesis
- N5,N10-Methylene THF provides the methyl group that is needed to convert dUMP to dTMP
- The product of this reaction is DHF; DHF is reduced to THF by dihydrofolate reductase
- THF is converted to N5,N10-Methyliene THF once again
Action of hydroxyurea
Inhibits ribonucleotide reductase
Action of 5-FU (5-fluorouracil)
Permanently inhibits thymidylate synthase by acting as its substrate and then permanently binding to it (thymidylate synthase converts dUMP to dTMP)
Action of methotrexate (MTX)
Inhibits dihydrofolate reductase (which converts DHF to THF)
Action of trimethoprim (TMP)
Inhibits bacterial dihydrofolate reductase (which converts DHF to THF)
De novo purine synthesis
• General: start with sugar and phosphate (PRPP) and then build the base on top
• Requires aspartate, glycine, glutamine, and THF for de novo synthesis
1. IMP is made from PRPP through a series of steps requiring glutamine, glycine, N10-Formyl-THF, and Aspartate
2. IMP can then be converted to AMP and GMP
Action of 6-MP (6-mercaptopurine)
Blocks de novo purine synthesis by inhibiting the first enzyme that adds an amine group to PRPP
Deoyribonucleotide reductase
Ribonucleotides are synthesized first and then converted to deoyribonucleotides by this enzyme
Ornithine transcarbamoylase deficiency
- OTC is a key enzyme in the urea cycle to help get rid of ammonia; it requires carbamoyl phosphate and ornithine
- OTC deficiency leads to an accumulation of carbamoyl phosphate, which is then converted to orotic acid
- There will also be a hyperammonemia
Orotic aciduria
- Inability to convert orotic acid to UMP due to defect in UMP synthase
- autosomal recessive
- Findings: increased orotic acid in urine, megaloblastic anemia (does not improve with administration of vitamin B12 or folic acid), failure to thrive
- Does not lead to hyperammonemia (OTC eficiency does lead to hyperammonemia with increase orotic acid)
- treatment: Oral administration of uridine
Adenosine metabolism
- AMP is converted to Adenosine (no phosphate)
- Adenosine is converted to inosine by adenosine deaminase
- Inosine gets its sugar removed and become Hypoxanthine
- Hypoxanthine is converted to xanthine by Xanthine oxidase
- Xanthine is converted to Uric acid by xanthine oxidase
Guanosine metabolism
- GMP is converted to Guanosine (no phosphate)
- Guanosine gets its sugar removed and becomes Guanine
- Guanine gets converted to Xanthine
- Xanthine is converted to uric acid by xanthine oxidase
Purine salvage
- Adenine can become AMP with the addition of PRPP; this is catalyzed by APRT (Adenine phosphoribosyltransferase)
- Guanine can become GMP with the addition of PRPP; this is catalyzed by HGPRT (Hypoxanthin-guanine phosphoribosyltransferase)
- Hypoxanthine can become IMP with the addition of PRPP; this is catalyzed by HGPRT
Adenosine deaminase deficiency
- One of the major causes of SCID (Severe Combined Immunodeficiency Disease), which affects kids
- autosomal recessive
- Leads to an excess of ATP and dATP, which then inhibit ribonucleotide reductase activity
- reduced DNA synthesis disproportinately affects lymphocytes, leading to decreased lymphocyte count
- first disease to be treated by experimental human gene therapy
Lesch-Nyhan syndrome
- Absence of HGPRT leads to defective purine salvage, excess uric acid production, and de novo purine synthesis {He’s Got Purine Recovery Trouble}
- X-linked recessive
- findings: retardation, self-mutilation, aggression, hyperuricemia, gout, choreoathetosis
Features of the gentic code
- Unambiguous
- Redundant/degenerate (exceptions: Methionine and tryptophan encoded by only one codon)
- Comaless/nonoverlapping (exception: some viruses)
- Universal: genetic code is conserved throughout evolution (exception of mitochondria in humans)
Silent mutation
Same amino acid (often due to change in 3rd position–tRNA wobble)
Missense mutation
- Changed amino acid
* Conservative mutation: new amino acid is similar chemically
Nonsense mutation
Results in early stop codon
Frameshift mutation
Results in misreading of all nucleotides downstream; can lead to truncated, nonfunctional protein
Origin of replication
- Consensus sequence where DNA replication begins
* may be single (prokaryotes) or multiple (eukaryotes)
Replication fork
Y-shaped region on DNA template where leading and lagging strands are synthesized
Helicase
Enzume that unwinds DNA template at replication fork
Single-stranded binding proteins
Prevent strands from reannealing
DNA topoisomerases
- Cerate a nick in the helix to relieve supercoils created during replication
- Fluoroquinolones inhibit DNA gyrase (prokaryotic topoisomerase II)
Enzyme inhibited by Fluoroquinolones
DNA gyrase (prokaryotic topoisomerase II)
Primase
Makes an RNA primer on which DNA polymerase III can initiate replication
DNA polymerase III
- Prokaryotic only
- Elongates leading strand by adding deoxynucleotides to the 3’ end
- Has 3’-5’ exonuclease activity for proofeading newly-added nucleotides
- Elongates the lagging strand until reaching a primer
DNA polymerase I
- Prokaryotic only
* Degrades the RNA primer (in 5’-3’ fashion) and replaces it with DNA
DNA ligase
Catalyzes phophodiester bond of Okazaki fragments
Telomerase
- Adds DNA to 3’ ends of chromosomes
* This prevents the loss of genetic material with every duplication
Nucleotide excision repair
- for bulky helix-distorting lesions, usually UV DNA damaged (thymine dimers, etc.)
- Endonucleases remove the oligonucletide containing the damaged bases and then DNA Polymerase and ligase fill and release the gap
- mutated in xeroderma pigmentosum; this prevents the repair of pyrimidine dimers due to UV light exposure
Enzymes that are mutated in xeroderma pigmentosum
Nucleatide excision repair enzymes
Base excision repair
- For small, non-bulky lesions
- Glycosylases recognize and remove damaged bases themselves, leaving an apurinic/apyrimidinic site; Apurinic/apyrimidinic endonuclease cuts DNA at these sites, and then the empty sugar is replaced by DNA polymerase
- This is an important mechanism in the repair of spontaneous/toxic deamination
Mismatch repair
- Newly-synthesized mismatched pairs are recognized, removed, and the gap is filled and resealed
- This mechanism is mutated in hereditary nonpolyposis colorectal cancer (HNPCC)
DNA repair mechanism affected in hereditary nonpolyposis colorectal cancer (HNPCC)
Mismatch repair
Nonhomologous end joining
- Joins double-stranded breaks of DNA fragments; no homology is required
- mutated in ataxia telangiectasia
Process mutated in ataxia telangiectasia
nonhomologous end joining
Direction of DNA and RNA synthesis
- 5’ to 3’
* a 3’ OH is required in the chain to attack the triphosphate bond is in the 5’ end of the incoming base
Direction of protein synthesis
- N-terminus to C-terminus
* mRNA is read 5’ to 3’
Types of RNA
- rRNA is the most abundant {rampant}
- mRNA is the longest {massive}
- tRNA is the smallest {tiny}
mRNA start codon
- AUG (rarely GUG or others in mitochondria or bacteria) {AUG inAUGurates protein synthesis}
- in eukaryotes the start codon coes for methionine, and it may be removed before translation is completed
- in prokaryotes it codes for formylthemionine (f-met)
mRNA stop codons
- UGA {U Go Away}
- UAA {U Are Away}
- UAG {U Are Gone}
Promoter
- Site upstream of gene location where RNA polymerase and other transcritpion factors bind to DNA
- AT-rich sequence with TATA and CAAT boxes
- mutations here lead to dramatic decrease in gene transcription